Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma.Barbro Linderholm, Roger Henriksson, Björn Tavelin et al.|Journal of Clinical Oncology|1998Cited by 270
Correlation of Vascular Endothelial Growth Factor Content With Recurrences, Survival, and First Relapse Site in Primary Node-Positive Breast Carcinoma After Adjuvant TreatmentBarbro Linderholm, Roger Henriksson, Kjell Grankvist et al.|Journal of Clinical Oncology|2000Cited by 254
p53 and vascular-endothelial-growth-factor (VEGF) expression predicts outcome in 833 patients with primary breast carcinomaBarbro Linderholm, Roger Henriksson, Birgitta Lindh et al.|International Journal of Cancer|2000Cited by 155
Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.Åke Öberg, G Lindmark, Matti Höyhtyä et al.|PubMed|2000Cited by 111
Low tumour cell proliferation at the invasive margin is associated with a poor prognosis in Dukes’ stage B colorectal cancersRichard Palmqvist, Roger Stenling, Petter Sellberg et al.|British Journal of Cancer|1999Cited by 82